AstraZeneca Pharma India receives permission for paediatric drug
It paves way for the launch of Selumetinib 10 mg & 25 mg capsule in India, subject to the receipt of related statutory approvals and licenses
It paves way for the launch of Selumetinib 10 mg & 25 mg capsule in India, subject to the receipt of related statutory approvals and licenses
Lonza, a global manufacturing partner to the pharma, biotech and nutrition industries, has announced it will invest in additional drug product manufacturing capabilities in Switzerland
The council has also reduced the GST to 5 per cent on a few more Covid-19 medicines
The board has approved the settlement of US $ 248 million towards Direct Purchaser group and Retailer Opt-Out group subject to court approval
Extension of hypericin orphan designation beyond cutaneous T-cell lymphoma
The panel is headed by DCGI Dr VG Somani with representatives from various state drug regulators and health ministry
According to WHO, over 1.5 million people died of TB in 2020
At present 18 per cent of the local pharmaceutical market is under government's price control
The drug is also intended for the treatment of glioblastoma multiforme
Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsules, USP are available in one strength of 5 mg/2.5 mg capsules in bottle count sizes of 100
Subscribe To Our Newsletter & Stay Updated